Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Iwaki Yuichi, Chairman & CEO. Director active across 2 companies, notably MEDICINOVA INC. Cumulatively, 1 reports have been recorded. History available since 9 July 2021. The latest transaction was disclosed on 9 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Yuichi Iwaki is the President and CEO of Medicinova Inc. He is responsible for the strategic direction of the company, focused on developing innovative treatments for neurological diseases. His leadership is crucial to Medicinova's mission of improving patients' lives.